Published in
BioMed Central, Pediatric Rheumatology, 1(14)
DOI: 10.1186/s12969-016-0112-6
Links
Tools
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 cases
This paper is made freely available by the publisher.
Full text: Download
Data provided by 